Learn More
Medchemexpress LLC Ipatasertib | 1001264-89-6 | C24H32ClN5O2 | 1 ML

Supplier: Medchemexpress LLC HY1518610MM/1ML
Ipatasertib (GDC-0068) is an orally active, highly selective, and ATP-competitive pan-Akt inhibitor with IC50 values of 5, 18, and 8 nM for Akt1, Akt2, and Akt3, respectively. It synchronously activates FoxO3a and NF-κB by inhibiting Akt, leading to p53-independent activation of PUMA. Ipatasertib also induces apoptosis in cancer cells and inhibits tumor growth in xenograft mouse models.
- Orally active
- Highly selective and ATP-competitive pan-Akt inhibitor
- Induces apoptosis in cancer cells
- Inhibits tumor growth in xenograft mouse models
- Purity: 99.79%
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.